R117h kalydeco FDA committee meeting

S

stephen

Guest
Aboveallislove,

Thanks for the heads up.

Although I don't have the R117H mutation, I did send an email to to the FDA Advisory Committee at PADAC@fda.hhs.gov outlining my experiences with Kalydeco and asking them
to consider investigating its approval for additional CF mutations.
 
Top